The possible role of high risk HPV infection in Iraqi patients with colorectal cancer

Hujaz Ismail Abdulrazzaq Alqirbi; Heba F. Hassan; Basim Mohammed Khashman

doi:10.53730/ijhs.v6nS6.11458

Authors

Hujaz Ismail Abdulrazzaq Alqirbi Department of Microbiology, Al-kindy College of Medicine, Baghdad University, Iraq
Heba F. Hassan Department of Basic Sciences. College of Dentistry. University of Baghdad, Iraq
Basim Mohammed Khashman
basim@bccru.uobaghdad.edu.iq
National cancer research center (NCRC), University of Baghdad, Iraq

Keywords:

HPV, CRC, oncogenesis, oncovirus , IHC

Abstract

Aims: the aim of this study is RPD3 expression in clinicopathological characteristics in CRC patients and to study the existence of a relationship between CRC and HPV in samples of Iraqi patients. Material and methods: 30 samples of formalin-fixed, paraffin-embedded archival tissues from CRC patients were obtained, together with 10 samples of normal tissue (free cancer), for immunohistochemical analysis of RPD3 and HPV expression. Results: Immunohistochemical (IHC) staining revealed only four cases (15%) with HPV infections while PRD3 was expressed in 19 CRC samples (63.3 percent). The PRD3 expression ratio. It was found in only four (15%) of the CRC samples. At ≤ P 0. 05, there is no significant difference. Conclusion: The results of this study support RPD3 as a supplementary marker to identified histologic screening components; it could possibly be used for the prognosis and targeted therapy. In addition, we discovered a relation with both HPV infection and CRC as oncovirus and tumorigenic factor.

Downloads

Download data is not yet available.

References

Douaiher, J.; Ravipati, A.; Grams, B.; Chowdhury, S.; Alatise, O.; Are, C.(2017) Colorectal cancer-global burden, trends, and geographical variations. J. Surg. Oncol., 115, 619–630. [CrossRef] [PubMed]

Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A.(2018) Global cancer statistics 2018: GLOBOCAN estimates ofincidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 68, 394–424. [CrossRef]

Arnold, M.; Sierra, M.S.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F.(2017).Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66, 683–691. [CrossRef].

World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR). Continuous Update Project Report: Diet.

World Health Organization. Early detection of cancers common in the Eastern Mediterranean Region. (2018).

Soreide K, Nedrebo BS, Knapp JC, Glomsaker TB, Soreide JA, Korner H.(2009). Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: Potential implications for the surgical oncologist. Surg Oncology.;18(1):31–50.

Edderkaoui M, et al.(2016) HDAC3 mediates smoking-induced pancreatic cancer. Oncotarget.;7(7):7747–60.

Nemati M, et al.(2018). Deregulated expression of HDAC3 in colorectal cancer and its clinical significance. Adv Clin Exp Med.;27(3):305–11.

He P, et al.(2018).Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer. Int J Oncol.;52(4):1305–16.

Chen G, et al.(2019). Long noncoding RNA SBF2-AS1 promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression. J Cell Physiol.;234(10):18688–96.

Zahonero B, Parra M.(2012). Histone deacetylases and cancer. Mol Oncol; 6:579–589.

West AC, Johnstone RW.(2014).New and emerging HDAC inhibitors for cancer treatment. J Clin Invest; 124: 30–39.

Damin DC, M. B.Caetano MB, Rosito MA. et al.,( 2007). “Evidence for an association of human papillomavirus infection and colorectal. European Journal of Surgical Oncology, vol. 33, no. 5, pp. 569–574.

Lorenzon L, Ferri M, Pilozzi E, Torrisi M, Ziparo V & French D .( (2011) .Human papillomavirus and colorectal cancer: evidences and pitfalls of published literature. Int J Colorect Dis 26, 135–142.

15-Gornick M, Castellsague X, Sanchez G, Giordano T, Vinco M, Greenson J, Capella G, Raskin L, Rennert G, Gruber SB et al.( (2010). Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control 21, 737–743.

Taherian H, Tafvizi F, Fard Z & Abdirad A .( (2014) .Lack of association between human papillomavirus infection and colorectal cancer. Prz Gastroenterol ;9,280–284.

Basim M. Khashman, Suhad K. Karim and Ghada Nazar Al-Jussani.(2020). The oncogenic effect of EBV/HPV co infection in group of Iraqi women with cervical carcinoma. Biochemical and Cellular Archives, 20(2), pp. 6037–6040.

SAS. Statistical Analysis System, User's Guide. Statistical. Version 9.1th ed. 2018. SAS. Inst. Inc. Cary. N.C. USA.

Jiang Y, Hsieh J.(2014) HDAC3 controls gap 2/mitosis progression in adult neural stem/progenitor cells by regulating CDK1 levels. Proc NatlAcad Sci U S A.;111(37):13541–1356.

Weichert W, Roske A, Niesporek S, et al.(2008) Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: Specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res.;14(6):1669–1677.

Stimson L, Wood V, Khan O, Fotheringham S, La Thangue NB.(2009) HDAC inhibitor-based therapies and haematological malignancy. Ann Oncol; 20: 1293–1302.

Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH et al.(2009). Phase II multiinstitutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol; 27: 5410–5417.

Al Moustafa AE, Al-Awadhi R, Missaoui N, Adam I, Durusoy R, et al.(2014). Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions. Human Vaccines & Immunotherapeutics. 10:1812—21.

Galeone C, Pelucchi C & La Vecchia C (2012) Added sugar, glycemic index and load in colon cancer risk. Curr Opin Clin Nutr Metabol Care 15, 368–373.

Sieri S, Krogh V, Agnoli C, Ricceri F, Palli D, Masala G, Panico S, Mattiello A, Tumino R, Giurdanella MC et al. Dietary glycemic index and glycemic load and risk of colorectal cancer: results from the EPICItaly study. Int J Cancer (2015) 136, 2923–2931.

Varnai AD, Bollmann M, Griefingholt H, Speich N, Schmitt C, et al.(2006) HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. International Journal of Colorectal Disease.;21:135–42.

Ghabreau L, Segal ED, Yasmeen A, Kassab A, Akil N, et al.(2012). High-risk human papillomavirus infections in colorectal cancer in the Syrian population and their association with Fascin, P-cadherin and Id-1 expressions: a tissue microarray study. Clinical Cancer Investigation; J 1: 26–30.

Al Moustafa AE, Foulkes WD, Wong A, Jallal H, Batist G, et al.( 2004). Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene.;23:5252–6.

Yasmeen A, Hosein AN, Yu Q, Al Moustafa AE.( 2007). Critical role for D-type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB-2 cooperation. Cancer Science.;98:973–7.

Al Moustafa AE, Kassab A, Darnel A, Yasmeen A. (2008).High-risk HPV/ErbB-2 interaction on E-cadherin/catenin regulation in human carcinogenesis. Current Pharmaceutical Design.;14:2159–72.

Moustafa, A. A. , Al-Antary, N., & Yasmeen, A. (2016). High-Risk Human Papillomavirus and Colorectal Carcinogenesis. In (Ed.), Human Papillomavirus - Research in a Global Perspective. IntechOpen. https://doi.org/10.5772/63295.

Suryasa, W. (2019). Historical Religion Dynamics: Phenomenon in Bali Island. Journal of Advanced Research in Dynamical and Control Systems, 11(6), 1679-1685.

Thaib, P. K. P., & Rahaju, A. S. (2022). Clinicopathological profile of clear cell renal cell carcinoma. International Journal of Health & Medical Sciences, 5(1), 91-100. https://doi.org/10.21744/ijhms.v5n1.1846